Regeneron Pharmaceuticals Inc logo

Regeneron Pharmaceuticals Inc REGN

Market Closed
22 Nov, 20:00
NASDAQ (NGS) NASDAQ (NGS)
$
738. 00
-6.5
-0.87%
After Hours
$
739. 99
+2.06 +0.28%
98.44B Market Cap
24.52 P/E Ratio
0% Div Yield
1,029,400 Volume
42.79 Eps
$ 744.50
Previous Close
Day Range
737.63 751.4
Year Range
735.95 1,211.2
Regeneron Pharmaceuticals Inc logo
REGN Regeneron Pharmaceuticals Inc
31 Jan 2025 (69 Days)
11.38
Cons. EPS
-
EPS
Regeneron Pharmaceuticals Inc logo
REGN Regeneron Pharmaceuticals Inc
31 Oct 2024
11.69
Cons. EPS
12.46
EPS
Regeneron Pharmaceuticals Inc logo
REGN Regeneron Pharmaceuticals Inc
1 Aug 2024
10.61
Cons. EPS
11.56
EPS
Regeneron Pharmaceuticals Inc logo
REGN Regeneron Pharmaceuticals Inc
2 May 2024
10.09
Cons. EPS
9.55
EPS
Regeneron Pharmaceuticals Inc logo
REGN Regeneron Pharmaceuticals Inc
2 Feb 2024
10.73
Cons. EPS
11.86
EPS
Regeneron Pharmaceuticals Inc logo
REGN Regeneron Pharmaceuticals Inc
2 Nov 2023
10.72
Cons. EPS
11.59
EPS
Regeneron Pharmaceuticals Inc logo
REGN Regeneron Pharmaceuticals Inc
4 Nov 2016
2.71
Cons. EPS
3.13
EPS
Regeneron Pharmaceuticals Inc logo
REGN Regeneron Pharmaceuticals Inc
4 Aug 2016
2.65
Cons. EPS
2.82
EPS
Regeneron Pharmaceuticals Inc logo
REGN Regeneron Pharmaceuticals Inc
5 May 2016
2.58
Cons. EPS
2.57
EPS
Regeneron Pharmaceuticals Inc logo
REGN Regeneron Pharmaceuticals Inc
9 Feb 2016
3.36
Cons. EPS
2.83
EPS